Stocks Comparison
COSCIENS Biopharma vs Scientist Home Future Health: revenue, profit, margins and growth compared
COSCIENS Biopharma brought in $7.5M of revenue in fiscal 2025, Scientist Home Future Health $204.1K in fiscal 2025. COSCIENS Biopharma kept -138.1% of its revenue as net profit, Scientist Home Future Health -113.6%. Free cash flow was -$9.2M at COSCIENS Biopharma and -$323.1K at Scientist Home Future Health.
Side by side, latest fiscal year
| CSCID | SHFH | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $7.5M | $204.1K |
| Revenue growth | -21.8% | n/a |
| Net income | -$10.4M | -$231.7K |
| Net margin | -138.1% | -113.6% |
| Free cash flow | -$9.2M | -$323.1K |
| Free cash flow margin | -122.4% | -158.3% |
| Earnings per share (diluted) | -$3.27 | -$0.01 |
| Cash | $7.3M | $68.9K |
| Debt | n/a | n/a |
| Price to earnings | n/a | n/a |
| Market value | n/a | $40.3M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #133 of 160 · Consumer staples | #151 of 160 · Consumer staples |
Over the years
Questions about COSCIENS Biopharma and Scientist Home Future Health
Which is bigger by revenue, COSCIENS Biopharma or Scientist Home Future Health?
COSCIENS Biopharma is bigger by revenue: $7.5M in fiscal 2025, against $204.1K for Scientist Home Future Health in fiscal 2025.
Which keeps more of its revenue as profit, COSCIENS Biopharma or Scientist Home Future Health?
COSCIENS Biopharma had a net margin of -138.1% in fiscal 2025; Scientist Home Future Health had -113.6% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.